RxDoctor Payments Data

James Lindley, MD

Neurological Surgery · Savannah, GANPI 1205825338

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $19,130 of the $24,424 with a category attached, or 78.3%. Globus Medical accounts for 65.7% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $7,006 and has fallen 89.7% since, to $722 in 2025.

$24,424in general payments, 2019–2025

Across 122 payments — averaging $200.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$16K
  • Mirus, LLC$6K
  • Boston Scientific$1K
  • Acera Surgical, Inc.$139
  • Cerapedics Inc.$130
  • Stryker$129
  • plus $417 from 11 others
$44,797in research payments, 2019–2025

Across 10 payments — averaging $4479.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$21K
  • Premia Spine, Ltd.$16K
  • Tanabe Pharma America, Inc.$8K

What the payments were for

  • Royalty or licence$19,13078%
  • Consulting fees$3,00012%
  • Food & beverage$2,0648%
  • Education$2301%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,424 in reported general payments places this provider in the 75th percentile of 201 neurological surgery providers in Georgia.

See all neurological surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$535,328
Medicare patients
452
Services billed
2,987

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen384$5,484
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen270$4,530
Gabapentin84$1,373
Cephalexin67$487
Tramadol Hcl83$437
Pregabalin17$250
Methylprednisolone39$190
Cyclobenzaprine Hcl33$180
Tizanidine Hcl42$161
Acetaminophen-CodeineAcetaminophen With Codeine11$129
Clindamycin Hcl20$124
Carisoprodol22$123
Methocarbamol18$104
Diazepam26$27

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →